Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis

Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis

Abstract Background The impact of different anti-virus regimens on prognosis of Chronic hepatitis B (CHB) related cirrhosis remains to be explored. We aim to investigate whether CHB-related HCC patients receiving nucleoside analogue regimen or not have a different prognosis. Methods Two hundred fort...

Full description

Bibliographic Details
Main Authors: Ping Zhang, Qingli Liu, Mei Yuan, Lina Wang
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Infectious Agents and Cancer
Subjects:
Tenofovir
Chronic hepatits B
Hepatocellular carcinoma
Cirrhosis
Nucleus(t)ide analogues
Online Access:http://link.springer.com/article/10.1186/s13027-018-0203-8

Internet

http://link.springer.com/article/10.1186/s13027-018-0203-8

Similar Items